Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name (Ascending) Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
54868-0290-04 54868-0290 Medroxyprogesterone Acetate Provera Hormonal Therapy Progestin Oral June 3, 1959 June 30, 2011 No Longer Used
54868-1010-01 54868-1010 Medroxyprogesterone Acetate Provera Hormonal Therapy Progestin Oral June 3, 1959 June 30, 2011 No Longer Used
54868-1010-03 54868-1010 Medroxyprogesterone Acetate Provera Hormonal Therapy Progestin Oral June 3, 1959 June 30, 2011 No Longer Used
54868-1010-04 54868-1010 Medroxyprogesterone Acetate Provera Hormonal Therapy Progestin Oral June 3, 1959 June 30, 2011 No Longer Used
62484-0020-01 62484-0020 Purixan Purixan 20.0 mg/mL Chemotherapy Antimetabolite Purine Analog Oral April 28, 2014 In Use
62484-0020-02 62484-0020 Purixan Purixan 20.0 mg/mL Chemotherapy Antimetabolite Purine Analog Oral April 28, 2014 In Use
73207-0101-30 73207-0101 Ripretinib QINLOCK 50.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor KIT, PDGFRA Oral May 15, 2020 In Use
73207-0101-31 73207-0101 Ripretinib QINLOCK 50.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor KIT, PDGFRA Oral May 15, 2020 In Use
57902-0860-03 57902-0860 Samarium SM 153 Lexidronam Quadramet 50.0 mCi/mL Ancillary Therapy Radiopharmaceutical Samarium Sm 153 Intravenous May 19, 1997 In Use
11994-0016-01 11994-0016 samarium Sm 153 lexidronam Quadramet 50.0 mCi/mL Ancillary Therapy Radiopharmaceutical Samarium Sm 153 Intravenous May 19, 1997 In Use

Found 10,000 results in 13 milliseconds — Export these results